NCT06212128View on ClinicalTrials.gov

RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study

Active, not recruitingOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

May 31, 2022

Study Completion Date

December 30, 2024

Conditions
Rectal Cancer
Interventions
COMBINATION_PRODUCT

RAPIDO TNT

neoadjuvant therapy per RAPIDO protocol (Patients under RAPIDO group underwent 25Gy/5 sessions of short course radiotherapy followed by 6 cycles of neoadjuvant XELOX similar to that of the RAPIDO trial protocol)

COMBINATION_PRODUCT

LCRT

LCRT group underwent conventional 50Gy/25-28 sessions of long course radiotherapy with concurrent oral capecitabine

All Listed Sponsors
lead

Sengkang General Hospital

OTHER

NCT06212128 - RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study | Biotech Hunter | Biotech Hunter